医学
食管癌
肌萎缩
列线图
无线电技术
放射治疗
放射科
癌症
骨骼肌
核医学
内科学
作者
Kazuma Iwashita,Hikaru Kubota,Riku Nishioka,Yukio Emoto,Daisuke Kawahara,Takeshi Ishihara,Daisuke Miyawaki,Ikuno Nishibuchi,Yasushi Nagata,Ryohei Sasaki
出处
期刊:Anticancer Research
[Anticancer Research USA Inc.]
日期:2023-03-27
卷期号:43 (4): 1749-1760
被引量:5
标识
DOI:10.21873/anticanres.16328
摘要
Background/Aim: Sarcopenia is an independent survival predictor in several tumor types. Computed tomography (CT) is the standard measurement for body composition assessment. Radiomics analysis of CT images allows for the precise evaluation of skeletal muscles. This study aimed to construct a prognostic survival model for patients with esophageal cancer who underwent radical irradiation using skeletal muscle radiomics. Patients and Methods: We retrospectively identified patients with esophageal cancer who underwent radical irradiation at our institution between April 2008 and December 2017. Skeletal muscle radiomics were extracted from an axial pretreatment CT at the third lumbar vertebral level. The prediction model was constructed using machine learning coupled with the least absolute shrinkage and selection operator (LASSO). The predictive nomogram model comprised clinical factors with radiomic features. Three prediction models were created: clinical, radiomics, and combined. Results: Ninety-eight patients with 98 esophageal cancers were enrolled in this study. The median observation period was 57.5 months (range=1-98 months). Thirty-five radiomics features were selected by LASSO analysis, and a prediction model was constructed using training and validation data. The average of the accuracy, specificity, sensitivity, and area under the concentration-time curve for predicting survival in esophageal cancer in the combined model were 75%, 92%, and 0.86, respectively. The C-indices of the clinical, radiomics, and combined models were 0.76, 0.80, and 0.88, respectively. Conclusion: A prediction model with skeletal muscle radiomics and clinical data might help determine survival outcomes in patients with esophageal cancer treated with radical radiotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI